Spero Therapeutics Inc (SPRO)
0.9375
+0.01
(+1.59%)
USD |
NASDAQ |
Dec 24, 16:00
Spero Therapeutics Free Cash Flow (Quarterly): 12.76M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| CytomX Therapeutics Inc | -20.75M |
| Castle Biosciences Inc | 16.96M |
| Arbutus Biopharma Corp | -20.74M |
| PTC Therapeutics Inc | -87.77M |
| Equillium Inc | -7.657M |